U.S. Household Products Stock News

Zenas BioPharma has recently been highlighted for moving from a pre-revenue stage toward commercialization of its lead antibody therapy obexelimab, targeting IgG4-Related Disease, an area with no approved treatments. An interesting aspect of this story is Zenas’ reported cash position of about US$270,000,000 entering 2026, which supports its plans to expand a pipeline focused on B‑cell‑mediated autoimmune diseases while advancing obexelimab toward market. Against this backdrop, we’ll examine...

If you are looking at Fluor and wondering whether the current share price gives you good value, you are not alone. This article focuses squarely on what you might be paying for compared to what you are getting. After closing at US$50.91, the stock has seen a 1.4% decline over the last 7 days, a 10.2% gain over 30 days, a 22.1% return year to date, and a 37.9% return over the past year, which may change how investors think about both upside and risk. Recent attention on Fluor has been driven...

Exzeo Group has entered into a new partnership with Tokio Marine Highland to distribute TMH2O residential flood insurance. The collaboration expands Exzeo’s property insurance offerings and supports its ambitions as a multi-line, technology driven platform. For investors tracking NYSE:XZO, this announcement comes as the stock trades at $16.1, with a 3.7% gain over the past week and a 20.8% decline over the past month. Year to date, shares show a 29.3% decline, so this move may stand out as...

The Morning Bull - US Market Morning Update Tuesday, Mar, 3 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 1.5%, the Nasdaq 100 futures off nearly 2% and small cap Russell 2000 futures lower by about 2.6%. The pressure comes as the US 10 year Treasury yield holds near 4.04%, which keeps borrowing costs elevated for households and businesses, and as global government bond yields in the UK and Europe climb on renewed inflation worries tied to...

If you are wondering whether AutoZone's share price still reflects good value after a long run in the auto parts sector, this article will help you break that question into clear valuation checks. AutoZone shares most recently closed at US$3,882.47, with returns of 1.4% over 7 days, 4.8% over 30 days, 17.5% year to date, 11.6% over 1 year, 54.1% over 3 years and 212.8% over 5 years. This gives plenty of history for investors to consider. Recent news coverage around AutoZone has focused on...

Why Arhaus Stock Is Drawing Attention Now Arhaus (ARHS) has pulled back recently, with the share price down over the past month and past 3 months. This move is prompting investors to reassess how its current valuation lines up with the underlying business. The company reports annual revenue of US$1,379.2m and net income of US$67.3m, and some models suggest the shares trade at a sizeable discount to certain intrinsic value estimates. This can attract interest from value oriented investors. See...

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...

PulteGroup recently presented at the 47th Annual Raymond James Institutional Investor Conference and, through Pulte Homes, has broken ground on Hilliard Isle, a US$300 million, 900-acre master-planned community in Kissimmee featuring more than 2,000 homes and extensive resort-style amenities. These developments come as PulteGroup contends with slowing orders, margin pressure, and a declining backlog, while still outperforming recent earnings expectations through what management describes as...

LKQ (LKQ) has initiated a formal review of its business after renewed pressure from activist investors, putting potential asset sales or even a full company sale on the table for shareholders. See our latest analysis for LKQ. LKQ's formal review comes after a tough run for long term holders, with a 1 year total shareholder return decline of 19.3% and a 3 year total shareholder return decline of 38.1%. At the same time, the 90 day share price return of 12.3% suggests momentum has recently...

WD-40 Company recently expanded its board of directors to 10 members by appointing Ken Plunk, a former J&J Snack Foods chief financial officer and long-time Wal-Mart executive, to serve on its Audit and Finance Committees effective February 18, 2026. This appointment brings extensive financial, international operations, and risk oversight experience to WD-40’s board, potentially strengthening governance around capital allocation, global expansion, and operational efficiency. Next, we’ll...

In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$507.44 million for the year, alongside a larger net loss and a US$112,867,000 impairment of intangible assets, and it also issued 2026 net sales guidance of US$600 million to US$620 million. Glaukos has also filed a US$69.25 million shelf registration tied to an ESOP-related common stock offering, highlighting how the company is...

Why Church & Dwight is on investors’ radar today Church & Dwight (CHD) is drawing fresh attention after a period in which the share price and fundamentals have moved in different directions, prompting investors to reassess how the business is currently priced. The stock has returned about 8% over the past month and roughly 24% in the past 3 months, while the 1 year total return is a 6% decline. That split between recent momentum and longer term performance often leads investors to look more...

DT Midstream, Inc. reported full-year 2025 results showing sales rising to US$1,243 million and net income to US$441 million, alongside a 7% dividend increase to US$0.88 per share and a US$396.99 million shelf registration for 3,000,000 shares related to its ESOP. Management’s disclosure that its project pipeline is several times larger than the announced US$3.40 billion capital plan, with growth expected to outpace a 7% annualized rate through the rest of the decade, points to a materially...

Institutional Buying Puts Parsons in Focus Bastion Asset Management’s new fourth quarter position in Parsons (PSN), totaling 128,186 shares worth about US$8.04 million, has put fresh attention on the contractor’s government and infrastructure exposure. See our latest analysis for Parsons. Parsons’ share price closed at US$67.86 after a 2.82% 1 day share price return. Despite an 18.12% 90 day share price decline, the 1 year total shareholder return of 22.60% and 5 year total shareholder return...

Viridian Therapeutics (VRDN) is in focus after reporting a larger than expected Q4 2025 loss and lower than forecast revenue. Its lead thyroid eye disease candidate remains under FDA Priority Review and EMA review. See our latest analysis for Viridian Therapeutics. At a share price of US$30.25, Viridian’s 1 day share price return of 2.96% and 7 day share price return of 7.77% follow a weaker 30 day share price return of an 8.33% decline. The 1 year total shareholder return of 109.92%...

Revvity (RVTY) has recently drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. See our latest analysis for Revvity. With the share price at $95.59 and a 30 day share price return of 12.14% decline, recent weakness builds on a softer trend, as the 1 year total shareholder return of 13.16% decline and 3 year total shareholder return of 25.03% decline point to fading momentum despite...

Recent share performance and business profile Without a specific headline event driving trading activity today, Two Harbors Investment (TWO) has still drawn attention after a recent share price move, prompting investors to reassess its risk and income profile. The stock shows a 1 day return of around a 1% decline, with a 7 day move of about a 3% decline and a one month performance near an 11% decline, while the past 3 months sit modestly positive. Over longer periods, total returns are mixed,...

In February 2026, Stable Sea announced a partnership with dLocal to power low-cost, high-speed stablecoin-based B2B cross-border payments across more than 40 countries, using dLocal’s local payout rails. This collaboration highlights how dLocal is deepening its role in emerging-market payment infrastructure by combining its local rails with stablecoin settlement for large-ticket international transactions. Next, we’ll explore how integrating stablecoin rails into its cross-border platform...

Kadant Inc. recently reported its fourth-quarter and full-year 2025 results, showing quarterly sales of US$286.2 million and flat net income of US$24.03 million, alongside essentially unchanged earnings per share versus the prior year. For 2025 as a whole, Kadant’s sales were broadly stable at about US$1.05 billion, but full-year earnings per share from continuing operations eased, while management issued 2026 guidance that points to higher expected revenue and GAAP EPS. We’ll now examine...

Why Nektar Therapeutics Is On Investors’ Radar Today Nektar Therapeutics (NKTR) has caught investor attention after a period where its shares showed strong moves over the past month and past 3 months, contrasting with mixed shorter term returns. See our latest analysis for Nektar Therapeutics. At a share price of $68.36, Nektar’s recent 30 day share price return of 83.12% and year to date share price return of 57.44% sit alongside a very large 1 year total shareholder return. This suggests...

In February 2026, Travelers Companies launched its AI Claim Assistant, an agentic voice solution built on OpenAI models and APIs to handle auto damage claim calls, streamline submissions, and free claim professionals to focus on more complex issues while retraining call center staff into higher-value roles. The rollout highlights how Travelers is embedding advanced analytics and AI directly into its claims workflow, blending automation with live human support to potentially raise service...

What the No.3PLUS launch could mean for Olaplex Holdings (OLPX) Olaplex Holdings (OLPX) has launched No.3PLUS Complete Repair Treatment, a pre-shampoo product built on its Bond Building Technology and new Damage Defense Cationic Complex, supported by a broad retail rollout and a science themed marketing campaign. See our latest analysis for Olaplex Holdings. Despite today’s 5.6% one day share price decline, Olaplex’s 90 day share price return of 36.9% and 12.6% year to date gain suggest...

Oshkosh Defense recently announced a public-private partnership with the Marine Depot Maintenance Command to support advanced manufacturing, materiel support, and the Digital Manufacturing Exchange, enabling secure local production of validated vehicle parts for faster military repairs and improved fleet readiness. By sharing controlled technical data to authorize local part manufacturing while protecting intellectual property, Oshkosh is embedding itself more deeply in the U.S. military’s...

KeyCorp (KEY) is in focus after analysts revisited their views following recent quarterly results. At the same time, stubborn inflation data, credit risk worries, and a pickup in insider selling are tempering sentiment around the regional bank. See our latest analysis for KeyCorp. After a strong 14.39% 90 day share price return, KeyCorp’s 1 year total shareholder return of 30.36% contrasts with a slightly negative year to date share price move. This suggests momentum has cooled as inflation...